Log in

Craneware Share Forecast, Price & News

GBX 1,560
-35.00 (-2.19 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: GBX 1,560
50-Day Range
MA: GBX 1,684.70
52-Week Range
Now: GBX 1,560
Volume32,967 shs
Average Volume39,899 shs
Market Capitalization£418.49 million
P/E Ratio27.86
Dividend Yield1.62%
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company offers patient engagement solutions, such as InSight Medical Necessity, a software-as-a-service (SaaS) solution that provides medical necessity validation for United States payers and advance beneficiary notice creation; and Trisus Patient Payment, which provides hospitals and health systems to modernize patient payment. It also provides charge capture and pricing solutions, such as Chargemaster Toolkit, Chargemaster Toolkit Discovery Viewer, and Chargemaster Toolkit Corporate Discovery Viewer for capturing optimal legitimate reimbursement for providers; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Pricing Analyzer, a SaaS solution that simplifies the price modelling process; Reference Plus, a SaaS solution to perform Chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; and supporting modules, including Online Reference Toolkit, interface scripting module, and supplies assistant. In addition, the company provides Trisus Claims Informatics, a software that automates claim and coding reviews; InSight Audit, a Web-based audit management tool for healthcare organizations to manage government and commercial audits; and InSight Denials to analyze, track, trend, and report on denial data. Further, it provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.
Read More
Craneware logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.67 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services



Sales & Book Value

Annual Sales£71.41 million
Cash FlowGBX 166.17 per share
Book ValueGBX 251.10 per share



Market Cap£418.49 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 1,560
-35.00 (-2.19 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRW News and Ratings via Email

Sign-up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Craneware (LON:CRW) Frequently Asked Questions

How has Craneware's stock price been impacted by COVID-19?

Craneware's stock was trading at GBX 1,660 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CRW stock has decreased by 6.0% and is now trading at GBX 1,560.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Craneware?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Craneware in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Craneware

How often does Craneware pay dividends? What is the dividend yield for Craneware?

Craneware declared a dividend on Tuesday, March 3rd. Investors of record on Thursday, March 19th will be paid a dividend of GBX 11.50 per share on Thursday, April 16th. This represents a yield of 0.61%. The ex-dividend date is Thursday, March 19th. The official announcement can be seen at this link.
View Craneware's dividend history

What price target have analysts set for CRW?

4 brokers have issued 1 year price targets for Craneware's shares. Their forecasts range from GBX 2,200 to GBX 3,000. On average, they anticipate Craneware's share price to reach GBX 2,733.33 in the next year. This suggests a possible upside of 75.2% from the stock's current price.
View analysts' price targets for Craneware

Who are some of Craneware's key competitors?

What other stocks do shareholders of Craneware own?

Who are Craneware's key executives?

Craneware's management team includes the following people:
  • Mr. Keith Neilson, Co-Founder, CEO & Exec. Director (Age 50)
  • Mr. Craig Thomas Preston, CFO, Company Sec. & Exec. Director (Age 48)
  • Mr. Marty Smith, Chief Technology Officer
  • Mr. Derek W. Paterson, Chief Information Officer
  • Seth Droe, Exec. VP of Sales

What is Craneware's stock symbol?

Craneware trades on the London Stock Exchange (LON) under the ticker symbol "CRW."

How do I buy shares of Craneware?

Shares of CRW and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Craneware's stock price today?

One share of CRW stock can currently be purchased for approximately GBX 1,560.

How big of a company is Craneware?

Craneware has a market capitalization of £418.49 million and generates £71.41 million in revenue each year. Craneware employs 320 workers across the globe.

What is Craneware's official website?

The official website for Craneware is public.craneware.com.

How can I contact Craneware?

Craneware's mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company can be reached via phone at +44-131-5503100.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.